Literature DB >> 20166217

Osteoblastic induction on calcium phosphate cement-chitosan constructs for bone tissue engineering.

Michael D Weir1, Hockin H K Xu.   

Abstract

Calcium phosphate cement (CPC) is osteoconductive and moldable, and it can conform to complex cavity shapes and set in situ to form hydroxyapatite. Chitosan could increase the strength and toughness of CPC, but there has been no investigation on recombinant human bone morphogenic protein-2 (rhBMP-2) delivery via CPC-chitosan composite and its effect on osteogenic induction of cells. The objective of this research was to investigate the mechanical properties and osteoblastic induction of MC3T3-E1 cells cultured on CPC-containing chitosan and rhBMP-2. Cell viability for CPC with chitosan and rhBMP-2 was comparable with that of control CPC, whereas the CPC-chitosan composite was stronger and tougher than CPC control. After 14 days, osteoblastic induction was quantified by measuring alkaline phosphatase (ALP) activity. ALP (mean +/- SD; n = 6) of cells seeded on conventional CPC without rhBMP-2 was (143 +/- 19) (mM pNpp/min)/(mug DNA). The addition of chitosan resulted in an ALP of 161 +/- 27. Further addition of rhBMP-2 to the CPC-chitosan composite increased the ALP to 305 +/- 111 (p < 0.05). All ALP activity on CPC composites was significantly higher when compared with the 10.0 +/- 3.3 of tissue culture polystyrene (p < 0.05). Flexural strength of CPC containing 15% (mass fraction) chitosan was 19.8 +/- 1.4 MPa, which is more than double the 8.0 +/- 1.4 MPa of conventional CPC (p < 0.05). The addition of chitosan to CPC increased the fracture toughness from 0.18 +/- 0.01 MPa.m(1/2) to 0.23 +/- 0.02 MPa.m(1/2) (p < 0.05). The relatively high strength, self-hardening CPC-chitosan composite scaffold is promising as a moderate load-bearing matrix for bone repair, with potential to serve as an injectable delivery vehicle for osteoinductive growth factors to promote osteoblastic induction and bone regeneration. (c) 2010 Wiley Periodicals, Inc. J Biomed Mater Res, 2010.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20166217      PMCID: PMC2875315          DOI: 10.1002/jbm.a.32665

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  60 in total

Review 1.  Bone tissue engineering: state of the art and future trends.

Authors:  António J Salgado; Olga P Coutinho; Rui L Reis
Journal:  Macromol Biosci       Date:  2004-08-09       Impact factor: 4.979

2.  Proliferation and differentiation of MC3T3-E1 cells on calcium phosphate/chitosan coatings.

Authors:  J Wang; J de Boer; K de Groot
Journal:  J Dent Res       Date:  2008-07       Impact factor: 6.116

3.  Setting reaction and hardening of an apatitic calcium phosphate cement.

Authors:  M P Ginebra; E Fernández; E A De Maeyer; R M Verbeeck; M G Boltong; J Ginebra; F C Driessens; J A Planell
Journal:  J Dent Res       Date:  1997-04       Impact factor: 6.116

4.  Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.

Authors:  G E Friedlaender; C R Perry; J D Cole; S D Cook; G Cierny; G F Muschler; G A Zych; J H Calhoun; A J LaForte; S Yin
Journal:  J Bone Joint Surg Am       Date:  2001       Impact factor: 5.284

5.  Transforming growth factor-beta1 incorporation in an alpha-tricalcium phosphate/dicalcium phosphate dihydrate/tetracalcium phosphate monoxide cement: release characteristics and physicochemical properties.

Authors:  E J Blom; J Klein-Nulend; J G C Wolke; K Kurashina; M A J van Waas; E H Burger
Journal:  Biomaterials       Date:  2002-02       Impact factor: 12.479

6.  The use of porous calcium phosphate scaffolds with transforming growth factor beta 1 as an onlay bone graft substitute.

Authors:  Robert O Huse; P Quinten Ruhe; Johannes G C Wolke; John A Jansen
Journal:  Clin Oral Implants Res       Date:  2004-12       Impact factor: 5.977

Review 7.  Tissue engineering: orthopedic applications.

Authors:  C T Laurencin; A M Ambrosio; M D Borden; J A Cooper
Journal:  Annu Rev Biomed Eng       Date:  1999       Impact factor: 9.590

8.  Strong, macroporous, and in situ-setting calcium phosphate cement-layered structures.

Authors:  Hockin H K Xu; Elena F Burguera; Lisa E Carey
Journal:  Biomaterials       Date:  2007-05-26       Impact factor: 12.479

9.  The influence of novel bioactive glasses on in vitro osteoblast behavior.

Authors:  Silvia Foppiano; Sally J Marshall; Grayson W Marshall; Eduardo Saiz; Antoni P Tomsia
Journal:  J Biomed Mater Res A       Date:  2004-11-01       Impact factor: 4.396

Review 10.  Contemporary alternatives to synthetic bone grafts for spine surgery.

Authors:  Jared F Brandoff; Jeff S Silber; Alexander R Vaccaro
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2008-08
View more
  21 in total

1.  The effect of mineral coating morphology on mesenchymal stem cell attachment and expansion.

Authors:  Siyoung Choi; William L Murphy
Journal:  J Mater Chem       Date:  2012-12-28

2.  Mannitol-containing macroporous calcium phosphate cement encapsulating human umbilical cord stem cells.

Authors:  Minghui Tang; Michael D Weir; Hockin H K Xu
Journal:  J Tissue Eng Regen Med       Date:  2011-03-27       Impact factor: 3.963

3.  Natural and Genetically Engineered Proteins for Tissue Engineering.

Authors:  Sílvia Gomes; Isabel B Leonor; João F Mano; Rui L Reis; David L Kaplan
Journal:  Prog Polym Sci       Date:  2012-01-01       Impact factor: 29.190

4.  Quaternized chitosan inhibits icaA transcription and biofilm formation by Staphylococcus on a titanium surface.

Authors:  Zhao-Xiang Peng; Bing Tu; Yang Shen; Lin Du; Ling Wang; Sheng-Rong Guo; Ting-Ting Tang
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

5.  Human embryonic stem cell encapsulation in alginate microbeads in macroporous calcium phosphate cement for bone tissue engineering.

Authors:  M Tang; W Chen; M D Weir; W Thein-Han; H H K Xu
Journal:  Acta Biomater       Date:  2012-05-22       Impact factor: 8.947

6.  Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium.

Authors:  Ping Wang; Xian Liu; Liang Zhao; Michael D Weir; Jirun Sun; Wenchuan Chen; Yi Man; Hockin H K Xu
Journal:  Acta Biomater       Date:  2015-02-21       Impact factor: 8.947

7.  Injectable scaffolds: Preparation and application in dental and craniofacial regeneration.

Authors:  Bei Chang; Neelam Ahuja; Chi Ma; Xiaohua Liu
Journal:  Mater Sci Eng R Rep       Date:  2017-01       Impact factor: 36.214

8.  A self-setting iPSMSC-alginate-calcium phosphate paste for bone tissue engineering.

Authors:  Ping Wang; Yang Song; Michael D Weir; Jinyu Sun; Liang Zhao; Carl G Simon; Hockin H K Xu
Journal:  Dent Mater       Date:  2015-12-29       Impact factor: 5.304

9.  [A novel calcium phosphate cement pre-loaded with chitosan and small molecule adenosine for repairing large cranial defects in rats].

Authors:  Yu-Fan Chen; Bing Song; Zhen-Ting Liao; Zhong-Hao Deng; De-Sheng Wu; Shu-Hao Feng; Liang Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-06-20

10.  Local delivery of alendronate eluting chitosan scaffold can effectively increase osteoblast functions and inhibit osteoclast differentiation.

Authors:  Sung Eun Kim; Dong Hun Suh; Young-Pil Yun; Jae Yong Lee; Kyeongsoon Park; Jun-Young Chung; Deok-Won Lee
Journal:  J Mater Sci Mater Med       Date:  2012-08-01       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.